Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA.

scientific article published in February 1999

Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.19.2.266
P698PubMed publication ID9974406

P2093author name stringFarnier M
Athias A
Desrumaux C
Gambert P
Lagrost L
Bessède G
Vergès B
Perségol L
P433issue2
P407language of work or nameEnglishQ1860
P921main subjecthyperlipidemiaQ1079120
preproinsulinQ7240673
P304page(s)266-275
P577publication date1999-02-01
P1433published inArteriosclerosis, Thrombosis, and Vascular BiologyQ4797542
P1476titleMass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA.
P478volume19

Reverse relations

cites work (P2860)
Q31575347A hydrophobic cluster at the surface of the human plasma phospholipid transfer protein is critical for activity on high density lipoproteins
Q45041067Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample
Q35592465Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins
Q43992172Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity
Q44445906Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy
Q37119309Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development
Q47328678Early decreases in plasma lipid transfer proteins during weight reduction
Q33338480Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis
Q46865630Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus
Q44195493Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion
Q34657972Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology
Q34114968Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP).
Q33673882LXR-SREBP-1c-phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size
Q36343495New insight into the pathophysiology of lipid abnormalities in type 2 diabetes
Q44499489PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity
Q35350326Pathophysiology of diabetic dyslipidaemia: where are we?
Q52346293PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity.
Q44287744Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency
Q44053804Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E.
Q51505156Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.
Q37469242Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor
Q44380415Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus
Q43744167Plasma phospholipid transfer protein activity in patients with low HDL and cardiovascular disease treated with simvastatin and niacin
Q44457158Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men.
Q74106105Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity
Q79294210Quantitation of the active and low-active forms of human plasma phospholipid transfer protein by ELISA
Q33780365Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis.
Q33996892Reverse cholesterol transport in diabetes mellitus
Q35341853Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism
Q37100511Serum CETP and PLTP activity in middle-aged men living in urban or rural area of the Lower Silesia region. PURE Poland sub-study.
Q51741207Serum cholesteryl ester transfer protein concentrations are associated with serum levels of total cholesterol, beta-lipoprotein and apoproteins in patients with type 2 diabetes mellitus.
Q43182286Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes
Q73644431Study of vitamin E net mass transfer between alpha-tocopherol-enriched HDL and erythrocytes: application to asymptomatic hypercholesterolemic men
Q34187337The impact of phospholipid transfer protein (PLTP) on HDL metabolism
Q44955621Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations

Search more.